Representative before the EPO

Employment test 11 - 50 employees
Company dna df mp
operating since 2000
Headquarter in Munich
active in Legal Services and IP Consulting

We have observed 114 EP applications Sandra M. Pohlman has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11705137

EXTENDED RELEASE POWDER AND AQUEOUS SUSPENSION COMPRISING METHYLPHENIDATE

IPC classification:
A61K 9/00, A61K 9/50, A61K 31/4458
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13179021

Nrf2 screening assays and related methods and compositions

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Biogen Idec MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12712191

COMPOUNDS AND METHODS FOR PREPARATION OF DIARYLPROPANES

IPC classification:
C07C 41/18, C07C 43/205, C07C 43/23, C07C 45/45, C07C 49/84
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12781824

MAGNETIC GRAPHENE-LIKE NANOPARTICLES OR GRAPHITIC NANO-OR MICROPARTICLES AND METHOD OF PRODUCTION AND USES THEREOF

IPC classification:
B32B 9/00
Applicant:
The State University of New York
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12729396

POLYCISTRONIC EXPRESSION SYSTEM FOR BACTERIA

IPC classification:
C12N 15/63, C12N 15/90, C12R 1/46
Applicant:
Actogenix N.V.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Andrej Michalík, De Clercq & Partners cvba
Status:
GRANT OF PATENT INTENDED
EP12725988

CB-183,315 COMPOSITIONS AND RELATED METHODS

IPC classification:
A61K 9/14, A61K 9/20
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12789291

METHODS OF TREATING MULTIPLE SCLEROSIS AND PRESERVING AND/OR INCREASING MYELIN CONTENT

IPC classification:
A01N 37/00, A61K 31/19
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12796164

PROCESS FOR PREPARING HIGH PURITY AND CRYSTALLINE DIMETHYL FUMARATE

IPC classification:
C07C 69/74
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12797633

METHOD AND DEVICE FOR NON-INVASIVE ACOUSTIC STIMULATION OF STEM CELLS AND PROGENITOR CELLS IN A PATIENT

IPC classification:
C12N 13/00
Applicant:
The State University of New York
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12801986

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER

IPC classification:
C40B 30/04
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12802595

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF BLADDER CANCER

IPC classification:
C12Q 1/68, G01N 33/574
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12762404

MATERIALS AND METHOD FOR TREATING INTERNAL BODY CAVITIES

IPC classification:
A61K 9/00, A61K 47/10, A61K 47/34, A61K 47/38
Agent:
Multiple attorneys, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
EXAMINATION IN PROGRESS
EP12814463

PRODUCTION OF THERMOREVERSIBLE HYDROGELS FOR THERAPEUTIC APPLICATIONS

IPC classification:
C08F 251/00
Agent:
Multiple attorneys, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
GRANT OF PATENT INTENDED
EP12773253

MODIFIED GRAM POSITIVE BACTERIA AND USES THEREOF

IPC classification:
C12N 1/04, A61K 39/09
Applicant:
Actogenix N.V.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Andrej Michalík, De Clercq & Partners cvba
Status:
GRANT OF PATENT INTENDED
EP12772891

MODIFIED GRAM POSITIVE BACTERIA AND USES THEREOF

IPC classification:
C12N 1/04, C12R 1/225, A23L 1/30, A61K 35/74
Applicant:
Actogenix N.V.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Andrej Michalík, De Clercq & Partners cvba
Status:
EXAMINATION IN PROGRESS
EP12775896

PREDICTING TUMOR RESPONSE TO ANTI-ERBB3 ANTIBODIES

IPC classification:
G01N 33/574
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13731180

VIABILITY STAINING METHOD

IPC classification:
G01N 33/542, G01N 33/569, G01N 33/58
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
PATENT GRANTED
EP12848809

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF BLADDER CANCER

IPC classification:
C12Q 1/68, G01N 33/53
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13730384

METHOD OF DETECTING VIABLE CELLS IN A CELL SAMPLE

IPC classification:
G01N 33/542, G01N 33/569, G01N 33/58
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12854260

NOVEL ENHANCED SELECTIN ANTAGONISTS

IPC classification:
A61P 29/00, C07K 14/00, C12N 15/62
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12857668

NOVEL ATTENUATED POLIOVIRUS: PV-1 MONO-CRE-X

IPC classification:
C12N 7/04
Applicant:
The State University of New York
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12856877

SILICON-CONTAINING FUMARIC ACID ESTERS

IPC classification:
C08F 4/44
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12760385

AUXIN PLANT GROWTH REGULATORS

IPC classification:
C05F 11/10, A01N 25/00, A01N 43/38, A01N 43/90, A01N 45/00, A01P 21/00
Applicant:
University of Alberta
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12859158

COMPOSITIONS AND METHODS FOR TREATMENT OF THROMBOSIS AND PROLONGING SURVIVAL OF STORED PLATELETS

IPC classification:
A61P 7/02
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12798073

IDENTIFICATION OF MULTIGENE BIOMARKERS

IPC classification:
C12Q 1/68
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12862137

METHODS FOR TREATMENT OF BREAST CANCER NONRESPONSIVE TO TRASTUZUMAB

IPC classification:
A61K 31/517, A61K 39/395
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12767342

AUTOLOGOUS HUMAN ADULT PLURIPOTENT VERY SMALL EMBRYONIC-LIKE (HVSEL) STEM CELL REGENERATION OF BONE AND CARTILAGE

IPC classification:
C12N 5/0735, C12N 5/074, A61K 35/54, A61L 27/38, A61L 27/58
Applicant:
University of Michigan
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13190594

Method of treating thermoregulatory disfunction with paroxetine

IPC classification:
A61P 5/24, A61P 15/12, A61K 31/4525
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13739003

DEUTERATED ALPHA-LIPOIC ACID

IPC classification:
C07D 339/04
Applicant:
Concert Pharmaceuticals Inc
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION REFUSED
EP13746306

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

IPC classification:
A61K 31/225
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Jones Day
Status:
GRANT OF PATENT INTENDED
EP13183732

Novel antibacterial agents for the treatment of GRAM positive infections

IPC classification:
C07K 7/08
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13179024

Nrf2 screening assays and related methods and compositions

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Biogen Idec MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13179016

Treatment for Amyotrophic Lateral Sclerosis

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Biogen Idec MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13179025

Nrf2 screening assays and related methods and compositions

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Biogen Idec MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13179023

Nrf2 screening assays and related methods and compositions

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Biogen Idec MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13713011

COMPOSITIONS AND METHODS FOR ORAL DELIVERY OF ENCAPSULATED DIETHYLENETRIAMINEPENTAACETATE PARTICLES

IPC classification:
A61P 39/04, A61K 9/48, A61K 9/50, A61K 31/198, A61K 31/315, A61K 45/06
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13768248

BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS

IPC classification:
C07K 14/495
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Applicant:
University of California
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13769361

IMAGING CELL SORTER

IPC classification:
C12M 1/00, C12M 1/34, C12Q 1/02, G01N 21/27, G01N 21/64, G01N 33/48, G01N 33/483, G01N 37/00
Applicant:
Tokyo Medical and Dental University
Applicant:
Kanagawa Academy of Science and Technology (KAST)
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP13187455

Recombinant anti-epidermal growth factor receptor antibody compositions

IPC classification:
C07K 14/71, C07K 16/28, A61K 39/395
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
The patent has been granted
EP13778205

LIPIDATED GLYCOSAMINOGLYCAN PARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS

IPC classification:
A61P 35/00, C12N 15/87, C12N 15/88, A61K 9/127, A61K 9/52, A61K 47/48
Applicant:
Ramot at Tel-Aviv University Ltd.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Becker Kurig Straus
Status:
GRANT OF PATENT INTENDED
EP13805132

COMPOSITIONS AND METHODS FOR SENSITIVE MUTATION DETECTION IN NUCLEIC ACID MOLECULES

IPC classification:
C12N 15/11, C12Q 1/68, G01N 33/53
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13797216

HUMAN VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS FOR TREATMENT OF OCULAR DISEASE

IPC classification:
A61K 35/12, A61K 35/28, A61K 35/48
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13799754

ANTIBODY AGAINST TRANSPORTER AND USE THEREOF

IPC classification:
C07K 16/28, C07K 16/46, C12N 5/10, C12N 15/09, C12P 21/08, A61K 39/395
Applicant:
Kinki University
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13745073

COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS

IPC classification:
A61P 29/00, A61K 9/00, A61K 31/137, A61K 31/215, A61K 31/275, A61K 31/47
Applicant:
Forward Pharma A/S
Agent:
Hoffmann Eitle PartmbB
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Henkel Breuer & Partner
Status:
EXAMINATION IN PROGRESS
EP13752782

METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET

IPC classification:
A61K 9/00, A61K 9/50, A61K 31/4458
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13169139

Compositions and uses for treating Multiple Sclerosis

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13844157

HUMAN ANTI-VEGFR-2/KDR ANTIBODIES

IPC classification:
A61P 35/00, C07K 16/28, A61K 39/395
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP15157323

INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN

IPC classification:
A61P 3/06, C07D 263/20, A61K 31/421
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP13818104

INTERFACE AND FLUID-TRANSFER SYSTEM

IPC classification:
G01N 1/10, G01N 1/22
Applicant:
EMD Millipore Corporation
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13827058

ANTI-GDF15 ANTIBODIES

IPC classification:
A61P 35/00, C07K 16/22, A61K 39/395
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13818154

ANTI-NOTCH3 ANTIBODIES

IPC classification:
C07K 16/28
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13786589

COMPOSITIONS AND METHODS FOR TRANSDERMAL DELIVERY OF AMPHETAMINE

IPC classification:
A61K 9/70, A61K 31/137
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
The patent has been granted
EP13821404

MULTI-POLYMER COMPOSITIONS FOR TRANSDERMAL DRUG DELIVERY

IPC classification:
A61K 9/70, A61K 31/4168
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP13821401

COMPOSITIONS AND METHODS FOR TRANSDERMAL DELIVERY OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS

IPC classification:
A61K 9/70, A61K 31/192
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14702977

SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM

IPC classification:
A61K 9/16, A61K 9/50, A61K 31/5513
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP14702134

CONTROLLED RELEASE FORMULATIONS OF LORAZEPAM

IPC classification:
A61K 9/20, A61K 31/5513
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14706709

ENHANCED PROBE BINDING

IPC classification:
C12Q 1/68
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP15174329

BAFF, INHIBITORS THEREOF AND THEIR USE IN THE MODULATION OF THE B-CELL RESPONSE

IPC classification:
A61P 9/00, A61P 9/12, A61P 13/12, A61P 31/18, A61P 35/00, A61P 37/02, A61K 38/17, A61K 39/395, A61K 48/00
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14717335

TREATMENT AND PREVENTION OF ACUTE KIDNEY INJURY USING ANTI-ALPHA V BETA 5 ANTIBODIES

IPC classification:
A61P 13/12, C07K 16/28, A61K 39/395
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14714130

STABLE TRANSDERMAL AMPHETAMINE COMPOSITIONS AND METHODS OF MANUFACTURE

IPC classification:
A61P 25/26, A61K 9/70, A61K 31/137
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14713016

BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/24, A61K 9/28, A61K 9/50, A61K 31/09, A61K 31/216
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
PATENT GRANTED
EP14759920

STEM CELL COMPOSITIONS AND METHODS FOR WOUND HEALING

IPC classification:
A61P 17/02, A61K 35/28
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12744715

ADJUVANT COMPOSITIONS WITH 4-IBBL

IPC classification:
A61K 39/39, A61K 47/06
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14724535

METHODS FOR ELECTRONIC KARYOTYPING

IPC classification:
C12Q 1/68
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14770186

COMPOSITIONS AND METHODS FOR TREATING MPSI

IPC classification:
C12N 7/00, C12N 7/01, C12N 15/00
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14763039

ATTENUATED INFLUENZA VIRUSES AND VACCINES

IPC classification:
A61P 31/16, C12N 7/04
Applicant:
The State University of New York
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15184650

DIMETHYL FUMARATE WITH GLATIRAMER ACETATE OR INTERFERON-BETA FOR TREATING MULTIPLE SCLEROSIS

IPC classification:
A61P 25/00, A61K 9/20, A61K 31/225, A61K 31/275, A61K 38/02, A61K 38/16, A61K 38/21
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14780396

ENHANCED NEUROPSYCHOLOGICAL ASSESSMENT WITH EYE TRACKING

IPC classification:
A61B 3/113, A61B 5/16
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14794253

DESIGN AND USE OF SPECIFIC REGULATORY T-CELLS TO INDUCE IMMUNE TOLERANCE

IPC classification:
C07K 14/725
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14755818

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

IPC classification:
A61K 9/28, A61K 31/225
Applicant:
Forward Pharma A/S
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Markus Breuer, Henkel Breuer & Partner
Status:
GRANT OF PATENT INTENDED
EP14755672

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

IPC classification:
A61K 9/28, A61K 31/225
Applicant:
Forward Pharma A/S
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Markus Breuer, Henkel Breuer & Partner
Status:
EXAMINATION IN PROGRESS
EP14852268

RHO KINASE INHIBITORS

IPC classification:
C07D 401/14
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP16163685

PARTICULATE COMPOSITIONS FOR DELIVERY OF POORLY SOLUBLE DRUGS

IPC classification:
A61K 9/14, A61K 9/50, A61K 31/135, A61K 31/4468, A61K 31/485
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14858814

FILTRATION SYSTEM AND USE THEREOF

IPC classification:
C12M 1/12, C12M 3/06, G01N 33/48
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP11826134

THE USE OF SPINOSYNS AND SPINOSYN COMPOSITIONS AS LOCAL ANESTHETICS AND AS ANTIARRHYTHMIC AGENTS

IPC classification:
A61P 9/06, A61P 23/02, A61K 31/7048, A61K 45/06
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14858138

METHOD FOR DETECTING VIABLE CELLS IN A CELL SAMPLE

IPC classification:
C12Q 1/06, G01N 33/52
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14824664

CONTROLLED RELEASE DOSAGE FORM FOR ONCE DAILY ADMINISTRATION OF DIMETHYL FUMARATE

IPC classification:
A61P 25/00, A61K 9/00, A61K 9/20, A61K 9/24, A61K 9/28, A61K 9/32, A61K 9/36, A61K 9/48, A61K 9/50, A61K 9/58, A61K 9/62, A61K 31/215
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14868918

PD-1 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREOF

IPC classification:
A61P 35/00, C07K 16/28, C12N 1/19, C12N 1/21, C12N 15/13, C12N 15/70, C12N 15/81, A61K 39/395
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14824323

COMPOSITIONS AND METHODS FOR TRANSDERMAL DELIVERY OF AMPHETAMINE

IPC classification:
A61K 9/70, A61K 31/137
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP16178877

INDUCTION OF MUCOSAL TOLERANCE TO ANTIGENS

IPC classification:
A61K 35/74, A61K 38/20, A61K 39/00, A61K 39/39, A61K 48/00
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION PUBLISHED
EP15712226

COMPOSITIONS USEFUL IN TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

IPC classification:
C07K 14/47, C12N 9/10, C12N 9/12, C12N 9/78, C12N 15/861, A61K 48/00
Applicant:
University of Pennsylvania
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15712240

DIMETHYL FUMARATE AND VACCINATION REGIMENS

IPC classification:
A61P 25/28, A61P 31/00, A61K 31/225, A61K 39/05, A61K 39/09
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15760794

TREATMENT OF BRAIN AND CENTRAL NERVOUS SYSTEM TUMORS

IPC classification:
A61P 35/00, C07D 239/94, A61K 31/517
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP16188566

NEUROPROTECTION IN DEMYELINATING DISEASES

IPC classification:
A61P 25/00, A61K 31/225
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP16179507

ANTI-BCMA ANTIBODIES

IPC classification:
C07K 16/28, A61K 39/395
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION PUBLISHED
EP15723410

USING B-CELL-TARGETING ANTIGEN IgG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES

IPC classification:
C07K 14/47, C07K 14/755, C07K 14/78, C07K 16/28
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP16200853

PAN-HER ANTIBODY COMPOSITION

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/32, A61K 39/395
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15811604

FAST ACTING ORALLY DISINTEGRATING FILM

IPC classification:
A61P 1/08, A61K 9/00, A61K 31/4178
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP16193284

HIGHLY SENSITIVE METHODS FOR ANALYSIS OF TROPONIN

IPC classification:
G01N 33/68
Applicant:
University of California
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP16189936

REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE MELOXICAM COMPOSITIONS

IPC classification:
A61K 9/14, A61K 31/5415
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP16195336

ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION

IPC classification:
A61P 1/04, A61P 25/02, A61P 37/02, C07K 16/28, G01N 33/53, G01N 33/533, A61K 39/395
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP17154984

REDUCED COLONIZATION OF MICROBES AT THE MUCOSA

IPC classification:
C12N 1/00
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP17154791

ANTI-TNF ALPHA PRODUCING LACTIC ACID BACTERIA FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

IPC classification:
A61P 1/00, C07K 16/24, C12N 1/12, C12N 1/16, C12N 15/74, C12N 15/81, A61K 35/74, A61K 35/744, A61K 36/06, A61K 36/064
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15747711

SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS

IPC classification:
A61K 9/70, A61K 31/137
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15750750

ARIPIPRAZOLE PRODRUG COMPOSITIONS

IPC classification:
A61K 9/00, A61K 9/14, A61K 31/00
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15750744

SIRP-ALPHA IMMUNOGLOBULIN FUSION PROTEINS

IPC classification:
C07K 16/46
Applicant:
Merck Patent GmbH
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15838658

RECODED ARBOVIRUS AND VACCINES

IPC classification:
C12N 7/00, C12N 7/01, A01N 65/00, A61K 39/12
Applicant:
The State University of New York
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15767053

HUMANIZED ANTI-ALPHA V BETA 5 ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP17159348

LACTOBACILLUS AND STREPTOCOCCUS PROMOTERS AND USES THEREOF

IPC classification:
C12N 5/10, C12N 15/74, C12R 1/225, C12R 1/46
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
The application has been published
EP15840274

CELLS EXPRESSING APOLIPOPROTEIN E AND USES THEREOF

IPC classification:
C07K 14/47, C12N 1/19, C12N 15/81, C12Q 1/02
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15804578

ANTI-MET ANTIBODIES AND COMPOSITIONS

IPC classification:
A61P 35/00, C07K 16/28
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15777810

METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT

IPC classification:
A61P 35/00, C07K 16/22, A61K 31/282, A61K 39/395
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15790410

DITERPENOID DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61P 25/28, C07D 307/58, C07D 407/06, C07D 411/06, C07D 413/06, A61K 31/341, A61K 31/36, A61K 31/39, A61K 31/423
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15791155

ANTI-GPIIB/IIIA ANTIBODIES AND USES THEREOF

IPC classification:
C07K 14/00, C07K 16/28, A61K 38/00, A61K 39/00, A61K 39/40
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15794008

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES

IPC classification:
A61P 7/02, A61P 7/04, C07K 14/745, C07K 16/28, A61K 39/395
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15804260

METHODS OF TREATING MULTIPLE SCLEROSIS

IPC classification:
A61P 25/02, A61K 31/225
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15857437

BIOREACTOR USING MACROALGAE

IPC classification:
C02F 3/32
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15813989

MULTIPLE SCLEROSIS TREATMENT REGIMEN USING DIMETHYL FUMARATE

IPC classification:
A61P 25/00, A61K 31/225
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP15871090

MULTIPLEXED SINGLE MOLECULE ANALYZER

IPC classification:
G01N 21/62, G01N 33/53, G01N 33/58
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP16748518

CHIMERIC ANTIGEN RECEPTORS

IPC classification:
A61P 35/00, A61P 37/04, C07K 5/107, C07K 14/47, C07K 14/705, C07K 14/715, C07K 19/00, C12N 5/10, C12N 15/62, A61K 35/12, A61K 38/16, A61K 39/00
Applicant:
University Health Network (UHN)
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP17174144

METHODS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC AGENT

IPC classification:
G01N 33/68
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
The application has been published
EP16714601

DRUG DELIVERY DOSE INDICATOR

IPC classification:
G06F 19/00, A61M 5/178, A61M 5/31, A61M 5/315
Applicant:
Biogen MA Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP16747221

STABLE TRIENTINE FORMULATIONS

IPC classification:
A61P 39/04, A62D 3/33, A61K 31/30
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made
EP16747144

REGULATION OF GENE EXPRESSION BY APTAMER-MEDIATED MODULATION OF ALTERNATIVE SPLICING

IPC classification:
C12N 15/11, C12N 15/63, C12N 15/85
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
Request for examination was made

Please Sign in to use this feature